 Product introduction

IDRA-21 is a benzothiadiazine-class compound featuring a unique heterocyclic structure that modulates glutamate receptor activity to influence neural signaling. In vitro studies demonstrate its ability to enhance synaptic plasticity. Its stable chemical properties make it suitable as a research tool compound.

 Feature

(1)High Selectivity: Targets specific receptor subtypes.
(2)Stability: Chemically stable at room temperature.

 Applications

IDRA-21, as an important research tool compound, demonstrates broad application value across multiple disciplines due to its unique molecular characteristics. In fundamental research, it serves not only for investigating molecular recognition mechanisms and as an organic synthesis intermediate (particularly in heterocyclic compound synthesis), but also as a reference standard supporting analytical method development. In applied research, IDRA-21 plays a pivotal role in biotechnology applications including functional material development and molecular probe construction. Of particular significance, experimental studies have revealed that IDRA-21 optimizes neural signal transmission, exhibiting potential to maintain cerebral vitality - a property that enables cognitive function enhancement and memory efficacy improvement.